Browse or download the latest product, clinical, and training resources.
Experimental video showcasing the anti-encrustation capability of Endura™ ureteral stents.
Summary report of bench-test and clinical data supporting Endura™ surface performance.
Structured training for distribution partners covering product knowledge, positioning, and customer support.
Onboarding support for hospital urology teams introducing Endura™ into their stenting workflow.
Evidence-backed product differentiation and support.
Offer a ureteral stent with both hydrophilic lubricity and anti-encrustation surface technology - a compelling dual-surface story.
Multiple diameters, lengths, and set configurations to match diverse hospital procurement requirements.
Crevia Medical providesdistributor training, marketingcollateral, and clinical support materials.
We equip distribution partners with a clear value message built on differentiated surface performance.
CatheGenix is expanding its Endura™ distribution network. We welcome enquiries from distributors in all major markets. Please contact us to discuss regional availability.
We work with distributors to define appropriate inventory levels, lead times, and supply arrangements based on market needs.
CatheGenix provides product brochures, IFU, clinical evidence summaries, and training support materials for distribution partners.
Endura™ anti-encrustation hydrophilic ureteral stent platform designed for smoother placement, reliable drainage, and easier removal!
Product availability, indications, specifications, and regulatory status may vary by country or region.
Products are intended for use by qualified healthcare professionals.
Claims are subject to applicable approvals and supporting documentation in the relevant market.
